ArticleLiver cancer2026

Survival Benefit of Combined Systemic and Locoregional Therapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score-Matched Analysis.

Fan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.